Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly
- 1 May 2011
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Clinical Pharmacology
- Vol. 6 (2), 125-129
- https://doi.org/10.2174/157488411796151129
Abstract
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenonKeywords
This publication has 4 references indexed in Scilit:
- Near-Death States Reported in a Sample of 50 MisusersSubstance Use & Misuse, 2010
- A fatal poisoning involving Bromo-DragonflyForensic Science International, 2009
- Liquid chromatography–atmospheric pressure ionization electrospray mass spectrometry determination of “hallucinogenic designer drugs” in urine of consumersJournal of Pharmaceutical and Biomedical Analysis, 2008
- Drugs on the web; the Psychonaut 2002 EU projectProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006